Apexigen to Participate in Upcoming Investor Conferences

SAN CARLOS, Calif., July 08, 2021 (GLOBE NEWSWIRE) -- Apexigen, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing a new generation of antibody therapeutics for oncology, today announced that Xiaodong Yang, M.D., Ph.D., President and Chief Executive Officer, and Linda Rubinstein, Chief Financial Officer, will participate in...

Click to view original post